32nd Congress of the ESP and XXXIII International Congress of the IAP
Glasgow 2020: A Vision for the Future
29 August – 2 September 2020 | Glasgow, UK
ESP website
32nd ESP Congress & XXXIII IAP Congress in Glasgow
Congress
ECP 2019 Nice
Presentations
Sunday, 8 September 2019
Congress
Welcome Address
General Information
Welcome to Glasgow
Social Events & Tours
Downloads
Related Meetings / Media Partners
Committees & Organiser
CME Accreditation
Congress Newsletter
ECP 2019 Nice
Request Certificate
Gallery
Awardees
Industry Partners
Presentations
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Abstracts
Guidelines for Submission
Bursaries
Format Descriptions
Best Oral and Poster Prizes
Registration & Hotels
Registration Fees
Group Registration
Accommodation
Online Registration
Scientific Programme
Scientific Contents
Molecular Pathology Diagnostics Symposium
Computational Pathology Symposium
Sponsors & Exhibitors
General Information
Acknowledgements
My Account
Create Account
Congress Account
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Sunday, 8 September 2019
08:30 - 12:00
CP-01 | Computational Pathology Symposium - Morning Session
CP-01-001-Clinical-grade artificial intelligence: hype or hope for cancer care
CP-01-003-Building an AI school for pathology: workflow for Human-AI interfaces
LC-01 | Head and Neck Pathology: High quality reporting of head and neck cancers
LC-01-001-Introduction to ICCR - reporting of nasopharyngeal and oropharyngeal carcinomas
LC-01-002-Reporting of oral cavity carcinomas
LC-01-003-Reporting of carcinomas of the larynx and hypopharynx
LC-01-004-Reporting of salivary gland carcinomas
LC-01-005-Reporting of carcinomas of the nose and paranasal sinuses
LC-01-006-Reporting of neck dissection specimens
OFP-01 | Joint Session: Uropathology / Nephropathology
OFP-01-001-The influence of the presence of intraductal carcinoma of the prostate on the grade group systems prognostic performance
OFP-01-003-A new auto-annotation method and machine learning strategy for detection and annotation of cancer areas in prostate biopsies
OFP-01-004-Detection of PD-L1 RNA expression in immunohistochemically negative patients. Are the negatives a heterogenous group?
OFP-01-006-Intra and interpatient genetic features of intraductal carcinoma of the prostate
OFP-01-007-Papillary Renal Cell Carcinoma with prominent spindle cell stroma - tumour mimicking MESTK , clinicopathologic analysis of 5 cases
OFP-01-008-TFEB-amplified renal cell carcinoma: a comprehensive study of 7 novel cases
OFP-01-009-Improvement of vascular invasion scoring in stage I testicular non-seminomas to predict relapse during surveillance after orchiectomy
OFP-01-012-Immune cell infiltration in pediatric renal allografts: mononuclear phagocytes correlate with rejection, re-transplantation and fibrosis in a retrospective study
OFP-02 | Digestive Diseases Pathology - GI
OFP-02-001-Risk factors for intraductal tumour spread of submucosal gland in early squamous cell neoplasia: analysis of endoscopically resected specimens
OFP-02-002-Site of residual esophageal cancer after neo-adjuvant chemoradiotherapy with regard to the anatomical layers and radiation target volumes at histopathologic examination
OFP-02-003-Mechanotransduction in mice colon tumourigenesis : a pathologically reactivated physiological embryonic mechanosensitive pathway
OFP-02-004-The prognostic impact of the colorectal cancer microenvironment components and their spatial relationships
OFP-02-005-Cell line-derived xenografts: a possible in vivo model to investigate tumour budding in colorectal cancer
OFP-02-006-Comprehensive molecular analysis of recurrence in gastrooesophageal adenocarcinoma
OFP-02-008-Histopathological and molecular features of adenomatous and serrated colon adenomas, characteristics and overlapping features, challenges in the nomenclature
OFP-02-009-How many biopsies are needed to assess the Peritoneal Regression Grading Score (PRGS) in peritoneal metastasis?
OFP-02-011-Are tumor budding and tumor grade the same in colorectal cancer?
OFP-02-012-Expression of the inhibitory receptor CD94/NKG2A on CD8+ tumour-infiltrating lymphocytes in colorectal cancer: a new promising druggable immune checkpoint in a context of HLA-E/b2microglobuline overexpression by tumour cells
OFP-02-013-E-learning for instruction of scoring the tumour-stroma ratio (TSR) in colon carcinoma amongst international pathologists, as part of the UNITED study.
OFP-02-014-For better or worse: clinical correlation of SOX9 expression in irradiated rectal cancer
SPEC-01 | French Society of Pathology: Molecular pathology practice in Europe: how we do it
SPEC-01-001-Molecular pathology practice in Europe: an overview
SPEC-01-002-Molecular pathology practice in Germany
SPEC-01-003-Molecular pathology practice in the United Kingdom
SPEC-01-005-Molecular pathology practice in Spain
SPEC-01-006-Molecular pathology practice in Sweden
SPEC-01-007-Molecular pathology practice in France
SY-01 | Breast Pathology: New ideas in breast pathology (+Business Meeting)
SY-01-001-Invasive or not?
SY-01-004-Lobular carcinomas: not a single molecular entity
SY-02 | Gynaecological Pathology: New developments in cervical pathology
SY-02-002-Lower genital tract squamous neoplasia: classification, markers and recommendations
SY-02-004-NHPVA types of endocervical adenocarcinomas
SY-02-005-Update on adenosquamous lesions of the cervix: precursors and invasive carcinoma
SY-02-006-Update on reporting and issues in staging cervical cancer
SY-03 | Molecular Pathology: Proteomics (+Business Meeting)
SY-03-001-Proteomics of FFPE samples
SY-03-002-Cancer proteomics
SY-03-003-MALDI Imaging in pathology
VM-01 | Joint Session Cytopathology / Pulmonary Pathology: When cytology is more useful than histology
VM-01-001-Case 1
VM-01-002-Case 2
VM-01-004-Case 4
12:15 - 13:00
KL-01 | Keynote Lecture by Michael Middleton
KL-01-001-Imaging and pathology
14:45 - 16:45
CP-02 | Computational Pathology Symposium - DPA Session
CP-02-001-Embracing digital and computational pathology: a calling for pathologists as leaders in precision medicine
CP-02-002-Embedding AI into digital pathology workflows
CP-02-003-Enhancing digital pathology with artificial intelligence
SC-01 | Breast Pathology: Prognostic factors revisited
SC-01-002-Inflammatory breast cancer: the pathologists' perspective
SC-01-004-ASCO/CAP HER2 guidelines update
SC-02 | Head and Neck Pathology: Non-malignant diseases of the head and neck: in memory of Leslie Michaels
SC-02-003-Update on squamous intra-epithelial lesions of the larynx
SC-02-005-IgG4 related diseases of the head and neck
SS-01 | Gynaecological Pathology: Diagnostic mistakes in gynaecological pathology
SS-01-001-Case 1
SS-01-003-Case 3
SS-01-004-Case 4
SS-01-005-Case 5
SS-01-006-Case 6
SY-04 | Digestive Diseases Pathology: Microsatellite instability in tumours of the digestive tract: from bench to bedside
SY-04-003-Microsatellite instability testing: which analysis in routine practice for the pathologist?
SY-04-004-The next generation of microsatellite instability testing
SY-04-005-Immunotherapy in metastatic colo-rectal cancer (mCRC): the potential of immune checkpoint inhibitors
SY-05 | Joint Session Infectious Diseases Pathology / Molecular Pathology: Cancer and the microbioma
SY-05-001-Fusobacterium and colorectal cancer: fact or myth
SY-05-004-Panel Discussion: Cancer & microbiome - will the new knowledge impact future diagnostic pathology
SY-06 | Nephropathology: Mechanisms in renal diseases (+Business Meeting)
SY-06-005-Complement mediated glomerulopathies
VA-01 | Highlights of Virchows Archiv Annual Review 2020: what is new in soft tissue tumours?
VA-01-002-What is new in epithelioid soft tissue tumours?
VA-01-003-What is new in adipocytic neoplasia?
VA-01-006-What is new in the immunohistochemical and molecular genetic study of selected aspects of soft tissue tumours?
17:15 - 19:15
CP-03 | Computational Pathology Symposium - Evening Session
CP-03-000-Intro
CP-03-001-Deep learning enables fully automated mitotic density assessment in breast cancer histopathology
CP-03-002-Automated grading of urothelial cell carcinoma of the bladder
CP-03-003-Unsupervised anomaly detection: application to colorectal liver metastasis
CP-03-004-Automated Ki67 hot-spot detection and analysis leads to higher Ki67 proliferation indices
CP-03-005-U-Net ensembles for accurate classification of oesophageal adenocarcinoma
CP-03-006-Artificial intelligence driving automated pathology: iCAIRD and beyond
OFP-03 | Cytopathology
OFP-03-001-Negative ThyroSeq® genomic testing for indeterminate thyroid nodules: the memorial sloan kettering cancer center experience
OFP-03-002-Ultrasound guided fine needle aspiration of thyroid: inadequacy rate with rapid on site evaluation
OFP-03-004-The value of fine needle aspiration cytology in the examination of parathyroid lesions; role of immunocytochemistry and washout fluid analysis
OFP-03-006-BRAF mutation prediction from metastatic melanoma cytological smear using deep learning: an ongoing project
OFP-03-007-Metabonomics profiling of malignant peritoneal effusion with 1H-NMR spectroscopy
OFP-03-009-Correlation between the ultrasound-guided thyroid fine-needle aspiration cytology with molecular testing and surgical histopathology results
OFP-03-011-Contribution of TERT promoter mutation status to preoperative diagnosis of thyroid carcinoma
OFP-03-012-Thyroid nodules with AUS/FLUS cytology: what happens next?
SC-03 | Joint Session Gynaecological Pathology / Uropathology: Tumours of the ovary and testis: an update
SC-03-001-Small cell carcinoma of the ovary of hypercalcaemic type: unravelling the mysteries of a tumour unique to the ovary
SC-03-002-Differential diagnosis of ovarian mucinous tumours
SC-03-003-Ovarian Sertoli-Leydig cell tumours
SC-03-004-Histologic heterogeneity of seminoma of the testes
SC-03-005-Non seminomatous germ cell tumours of the testes. An update
SS-02 | Joint Session Breast Pathology / Infectious Diseases Pathology: Infections of the breast
SS-02-001-Case 1
SS-02-002-Case 2
SS-02-003-Case 3
SS-02-004-Case 4
SS-02-006-Case 6
SS-03 | Head and Neck Pathology: Challenging diagnostic problems in head and neck pathology
SS-03-003-Case 3
SS-03-005-Case 5
SS-03-006-Case 6
SS-03-007-Case 7
SY-07 | Molecular Pathology: Molecular morphology
SY-07-001-New developments of in situ methods
SY-07-004-Immunohistochemistry in clinical research
SY-08 | Nephropathology: Renal transplant pathology: the French perspective
SY-08-005-i-IF/TA
SY-09 | Pathology in Favour of Developing Countries: Pathology in developing countries: from real-life experiences to expectations for a better future
SY-09-001-Pathology in the Horn of Africa: the APOF project in Somaliland
SY-09-002-Prevention and diagnosis of breast cancer in a conflict area: the experience in Herat, Afghanistan
SY-09-003-Pathology services in a low resource setting: University of Abuja Teaching Hospital, Abuja, Nigeria experience
SY-09-005-The many roads to diagnosis of tuberculosis: experience of a tertiary care centre in southwest coastal India
SY-09-006-Cytology as a tool in diagnosis of toxoplasma